Fundraising FoxSensa Neuroscience
1 known investors
Find your way into Sensa Neuroscience
Sign up to see every warm intro you have to Sensa Neuroscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensa Neuroscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.
Investors · 1
Frequently asked questions
- What does Sensa Neuroscience do?
- Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.
- Who are Sensa Neuroscience's investors?
- Sensa Neuroscience's investors include Bonaventure Equity, LLC.